Cargando…
Role of molecular genetics in the clinical management of cholangiocarcinoma
The incidence of cholangiocarcinoma (CCA) has steadily increased during the past 20 years, and mortality is increasing. The majority of patients with CCA have advanced or metastatic disease at diagnosis, and treatment options for unresectable disease are limited, resulting in poor prognosis. However...
Autores principales: | Normanno, N., Martinelli, E., Melisi, D., Pinto, C., Rimassa, L., Santini, D., Scarpa, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198375/ https://www.ncbi.nlm.nih.gov/pubmed/35696744 http://dx.doi.org/10.1016/j.esmoop.2022.100505 |
Ejemplares similares
-
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
por: Carotenuto, Marianeve, et al.
Publicado: (2022) -
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
por: Simbolo, Michele, et al.
Publicado: (2014) -
Molecular Pathogenesis of Cholangiocarcinoma
por: Labib, Peter L., et al.
Publicado: (2019) -
Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma
por: Charalampopoulos, Georgios, et al.
Publicado: (2023) -
Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population
por: Trachu, N, et al.
Publicado: (2017)